
VALANX sets up SAB to advance ADC therapeutics
Biotech company VALANX has unveiled its new Scientific Advisory Board as it prepares to advance antibody-drug conjugate (ADC) therapeutics. John Lambert has been appointed as Chair, with Morris Rosenberg and Peter de Waele serving on the board alongside him. Lambert is a leading expert in ADC discovery… Read More

